120 related articles for article (PubMed ID: 11972386)
21. Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis.
Uchida K; Seidenfeld J; Rademaker A; Oyasu R
Cancer Res; 1989 Oct; 49(19):5249-53. PubMed ID: 2504487
[TBL] [Abstract][Full Text] [Related]
22. Differential response of cervical intraepithelial and cervical carcinoma cell lines to transforming growth factor-beta 1.
De Geest K; Bergman CA; Turyk ME; Frank BS; Wilbanks GD
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):376-85. PubMed ID: 7835777
[TBL] [Abstract][Full Text] [Related]
23. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
Merali S; Clarkson AB
Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
[TBL] [Abstract][Full Text] [Related]
24. Difluoromethylornithine antagonizes taxol cytotoxicity in MCF-7 human breast cancer cells.
Das B; Rao AR; Madhubala R
Oncol Res; 1997; 9(11-12):565-72. PubMed ID: 9563003
[TBL] [Abstract][Full Text] [Related]
25. Alpha-difluoromethylornithine induction of apoptosis: a mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats.
Fong LY; Nguyen VT; Pegg AE; Magee PN
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):191-9. PubMed ID: 11303587
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid and interferon-alpha effects on cell growth and differentiation in cervical carcinoma cell lines.
Yokoyama M; Nakao Y; Iwasaka T; Pater A; Sugimori H
Obstet Gynecol; 2001 Aug; 98(2):332-40. PubMed ID: 11506854
[TBL] [Abstract][Full Text] [Related]
27. Polyamines as biomarkers of cervical intraepithelial neoplasia.
Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
[TBL] [Abstract][Full Text] [Related]
28. Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3.
Vlastos AT; West LA; Atkinson EN; Boiko I; Malpica A; Hong WK; Follen M
Clin Cancer Res; 2005 Jan; 11(1):390-6. PubMed ID: 15671570
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines.
Makena MR; Cho HE; Nguyen TH; Koneru B; Verlekar DU; Hindle A; Kang MH; Reynolds CP
Pediatr Blood Cancer; 2018 Dec; 65(12):e27447. PubMed ID: 30251395
[TBL] [Abstract][Full Text] [Related]
30. Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer.
Hwang WY; Park WH; Suh DH; Kim K; Kim YB; No JH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638596
[TBL] [Abstract][Full Text] [Related]
31. Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion.
Seidenfeld J; Komar KA
Cancer Res; 1985 May; 45(5):2132-8. PubMed ID: 3921237
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
[TBL] [Abstract][Full Text] [Related]
33. Chemoprevention trials and surrogate end point biomarkers in the cervix.
Mitchell MF; Hittelman WK; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Wharton JT; Hong WK
Cancer; 1995 Nov; 76(10 Suppl):1956-77. PubMed ID: 8634987
[TBL] [Abstract][Full Text] [Related]
34. Residual proliferative capacity in F9 teratocarcinoma stem cell cultures treated with alpha-difluoromethylornithine, an inducer of parietal endoderm differentiation.
Wallon M; Holm I; Thorsson L; Oredsson SM; Heby O
Cancer Lett; 1990 Apr; 50(2):103-7. PubMed ID: 2109649
[TBL] [Abstract][Full Text] [Related]
35. Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells.
Alexiou GA; Tsamis KI; Vartholomatos E; Peponi E; Tzima E; Tasiou I; Lykoudis E; Tsekeris P; Kyritsis AP
J Neurooncol; 2015 Jun; 123(2):217-24. PubMed ID: 25935110
[TBL] [Abstract][Full Text] [Related]
36. Difluoromethylornithine enhances the uptake of methylglyoxal-bis(guanylhydrazone) prior to inhibiting leukemic cell proliferation.
Maddox AM; Orengo I; Haddox MK
Chemotherapy; 1987; 33(2):110-22. PubMed ID: 3105968
[TBL] [Abstract][Full Text] [Related]
37. Differential response of normal, premalignant and malignant human oral epithelial cells to growth inhibition by chemopreventive agents.
D'Ambrosio SM; Gibson-D'Ambrosio R; Milo GE; Casto B; Kelloff GJ; Steele VE
Anticancer Res; 2000; 20(4):2273-80. PubMed ID: 10953285
[TBL] [Abstract][Full Text] [Related]
38. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
[TBL] [Abstract][Full Text] [Related]
39. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
[TBL] [Abstract][Full Text] [Related]
40. D,L-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, induces differentiation in MEL cells.
Choudhary SK; Sharma D; Dixit A
Cell Biol Int; 1999; 23(7):489-95. PubMed ID: 10728786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
